← Leaderboards
Louise C Showe
Wistar Institute
$10,986,130
Attributed
$12,994,667
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$12,994,667 · 10
By mechanism
U01$6,154,318 · 2
R01$3,433,946 · 2
P30$2,490,171 · 3
R21$511,582 · 2
S10$404,650 · 1
Top collaborators
- Qin Liu5 shared
- Qihong Huang1 shared
Most similar at Wistar Institute
Same institution · by research overlap
- Dario C. Altieri$49,807,901
- Qin Liu$2,476,314
- Qihong Huang$2,464,654
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionSamplingBaseResponseGenesResearch PersonnelCellsMicrornasEarly DiagnosisTrainingGene Expression ProfilingMalignant NeoplasmsDiagnosisScreeningMalignant Neoplasm Of LungAreaMicroarray AnalysisGene Expression ProfileGenomicsServicesFundingMessenger RnaTechnologyMethylation
Grant awards (35)
Genomics Shared Resource$221,010
P30 · FY2023 · CA · contact PI
Genomics Shared Resource$221,010
P30 · FY2022 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$448,182
U01 · FY2021 · CA · contact PI
Genomics Shared Resource$221,010
P30 · FY2021 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$608,274
U01 · FY2020 · CA · contact PI
Genomics Shared Resource$205,228
P30 · FY2020 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$819,590
U01 · FY2019 · CA · contact PI
Bioinformatics Shared Resource$263,055
P30 · FY2019 · CA · contact PI
Genomics Shared Resource$221,010
P30 · FY2019 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$786,485
U01 · FY2018 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$671,654
U01 · FY2017 · CA · contact PI
Development of circulating biomarker for lung cancer$193,212
R21 · FY2017 · CA · contact PI
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer$682,890
U01 · FY2016 · CA · contact PI
HDAC Inhibitors and CTCL$390,140
R01 · FY2013 · CA · contact PI
Genomics Facility$206,274
P30 · FY2013 · CA · contact PI
HDAC Inhibitors and CTCL$423,039
R01 · FY2012 · CA · contact PI
Genomics Facility$224,915
P30 · FY2012 · CA · contact PI
HDAC Inhibitors and CTCL$396,309
R01 · FY2011 · CA · contact PI
Genomics Facility$225,853
P30 · FY2011 · CA · contact PI
HDAC Inhibitors and CTCL$406,113
R01 · FY2010 · CA · contact PI
Genomics Facility$246,137
P30 · FY2010 · CA · contact PI
HDAC Inhibitors and CTCL$415,059
R01 · FY2009 · CA · contact PI
Genomics Facility$234,669
P30 · FY2009 · CA · contact PI
Comprehensive genomics using the Illumina Beadstation 500$404,650
S10 · FY2008 · RR · contact PI
Microarray Analysis of Responsiveness of CTCL IL-12$157,910
R01 · FY2008 · CA · contact PI
Microarray Analysis of Responsiveness of CTCL IL-12$306,522
R01 · FY2007 · CA · contact PI
Microarray Analysis of Responsiveness of CTCL IL-12$311,770
R01 · FY2006 · CA · contact PI
Microarray Analysis of Responsiveness of CTCL IL-12$315,409
R01 · FY2005 · CA
Microarray Analysis of Responsiveness of CTCL IL-12$311,675
R01 · FY2004 · CA
CTCL STAGING USING GENE EXPRESSION PROFILES$510,680
U01 · FY2003 · CA
CTCL STAGING USING GENE EXPRESSION PROFILES$502,278
U01 · FY2002 · CA
CTCL STAGING USING GENE EXPRESSION PROFILES$616,308
U01 · FY2001 · CA
GENE EXPRESSION IN CTCL PATIENTS IN IL 12 CLINICAL TRIAL$157,466
R21 · FY2001 · CA
CTCL STAGING USING GENE EXPRESSION PROFILES$507,977
U01 · FY2000 · CA
GENE EXPRESSION IN CTCL PATIENTS IN IL 12 CLINICAL TRIAL$160,904
R21 · FY2000 · CA